Aki Miyasaka
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Clinicopathological features and programmed death-ligand 1 immunohistochemical expression in a multicenter cohort of uterine and ovarian melanomas: a retrospective study in Japan (KCOG-G1701s).
Journal: Melanoma research
Published: April 04, 2022
Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas.
Journal: Biochemical and biophysical research communications
Published: March 13, 2019
Kaempferol, a natural dietary flavonoid, suppresses 17β-estradiol-induced survivin expression and causes apoptotic cell death in endometrial cancer.
Journal: Oncology letters
Published: April 01, 2018
Advanced Mucinous Adenocarcinoma Arising from a Mature Cystic Teratoma: A Case Report and Literature Review.
Journal: Case reports in oncology
Published: May 25, 2016
Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer.
Journal: Gynecologic oncology
Published: February 02, 2016
Characterization of TP53 and PI3K signaling pathways as molecular targets in gynecologic malignancies.
Journal: The journal of obstetrics and gynaecology research
Published: January 28, 2016
Synergistic antitumor effects of combination PI3K/mTOR and MEK inhibition (SAR245409 and pimasertib) in mucinous ovarian carcinoma cells by fluorescence resonance energy transfer imaging.
Journal: Oncotarget
Published: November 15, 2015
Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells.
Journal: Oncology letters
Published: July 25, 2015
Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy.
Journal: British journal of cancer
Published: July 09, 2015
Last Updated: 09/26/2026